Blood‐based proteomic signature of amyloidosis: identification of novel regulators of amyloid load
Alzheimer's & Dementia · 2026-06 · 22 (6)
DOI: 10.1002/alz.71611 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 22.06.2026. Verfasst von Yike Chen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Proteomics, Amyloidosis, Alzheimer Disease, Amyloid beta-Peptides. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, Foundation for the National Institutes of Health, Alzheimer's Association.
Abstract (Originalsprache)
INTRODUCTION Cerebral amyloidosis is a defining feature of Alzheimer's disease (AD), yet the molecular heterogeneity among amyloidbeta‐positive (Aβ+) individuals remains poorly defined. We aimed to map the proteomic correlates of cerebral amyloidosis and link them to clinical variability within Aβ+ individuals. METHODS We integrated quantitative amyloid PET with large‐scale plasma proteomics (∼7000 proteins; SomaScan version 4.1) in Knight Alzheimer's Disease Research Center and Bio‐Hermes cohorts ( n = 1429). Proteome‐wide association analyses identified proteins associated with amyloid load, followed by unsupervised clustering and pathway enrichment analyses. RESULTS We identified 454 amyloid‐associated proteins, of which 54 replicated cross‐cohort. A derived 54‐protein proteomic score correlated with amyloid burden, AD biomarkers, and clinical severity. Pathway analyses of clinically distinct protein clusters revealed coordinated enrichment of intracellular signaling, immune, and proteostasis modules. DISCUSSION These findings delineate the circulating proteomic signature of cerebral amyloidosis and support plasma proteomics as a complementary approach to phosphorylated tau at threonine 217 and amyloid PET for biological stratification and characterization of disease heterogeneity in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.
- NeuroGenomics and Informatics Center, Washington University School of Medicine, St. Louis, Missouri, USA.
- Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, Maryland, USA.
- Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
- Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.
- Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Muhammad Ali
Förderung
- NIA NIH HHS
- Foundation for the National Institutes of Health
- Alzheimer's Association
Zitieren
APA
Chen, Y., Duggan, M. R., Timsina, J., Xu, Y., Western, D., Gong, K., Liu, M., Budde, J., Schindler, S. E., Morris, J. C., Holtzman, D. M., Benzinger, T. L. S., Gordon, B. A., Moqri, M., Knight Alzheimer Disease Research Center (Knight‐ADRC), Ibanez, L., Walker, K. A., Cruchaga, C., & Ali, M. (2026). Blood‐based proteomic signature of amyloidosis: identification of novel regulators of amyloid load. Alzheimer's & Dementia, 22(6). https://doi.org/10.1002/alz.71611
Vancouver
Chen Y, Duggan MR, Timsina J, Xu Y, Western D, Gong K, et al. Blood‐based proteomic signature of amyloidosis: identification of novel regulators of amyloid load. Alzheimer's & Dementia. 2026;22(6). doi:10.1002/alz.71611
BibTeX
@article{Chen2026,
author = {Chen, Yike and Duggan, Michael R and Timsina, Jigyasha and Xu, Ying and Western, Daniel and Gong, Katherine and Liu, Menghan and Budde, John and Schindler, Suzanne E and Morris, John C and Holtzman, David M and Benzinger, Tammie L S and Gordon, Brian A and Moqri, Mahdi and Knight Alzheimer Disease Research Center (Knight‐ADRC), Knight Alzheimer Disease Research Center (Knight‐ADRC) and Ibanez, Laura and Walker, Keenan A and Cruchaga, Carlos and Ali, Muhammad},
title = {Blood‐based proteomic signature of amyloidosis: identification of novel regulators of amyloid load},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {6},
doi = {10.1002/alz.71611}
}
EUVIMED